[Drug approval : entrectinib and larotrectinib - cancers with NTRK fusion].

[Drug approval : entrectinib and larotrectinib - cancers with NTRK fusion]. Bull Cancer. 2020 Nov;107(11):1085-1086 Authors: Delaye M, Rodrigues M PMID: 33169692 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/33169692?dopt=Abstract

Source: Bulletin du Cancer - November 1, 2020 Category: Cancer & Oncology Authors: Delaye M, Rodrigues M Tags: Bull Cancer Source Type: research

More News: Cancer | Cancer & Oncology